Intra-arterial Drug Delivery for Brain Diseases

  • Jason A. EllisEmail author
  • Shailendra Joshi


This chapter describes the rationale for utilizing intra-arterial (IA) drugs in the treatment of brain tumors. The concepts presented hold true in general for the efficient delivery of agents that may treat a variety of other brain pathologies. We discuss novel insights into IA pharmacology and pharmacokinetic techniques that have emerged in the last decade. Theoretical and practical IA drug delivery optimization strategies for treating brain diseases are discussed in detail.


Brain tumor Glioma Drug delivery Blood flow Chemotherapy 

Suggested Reading

  1. Cooke JN, Ellis JA, Hossain S, Nguyen J, Bruce JN, Joshi S. Computational pharmacokinetic rationale for intra-arterial delivery to the brain. Drug Deliv Transl Res. 2016;6(5):622–9.CrossRefGoogle Scholar
  2. Ellis JA, Banu M, Hossain SS, Singh-Moon R, Lavine SD, Bruce JN, Joshi S. Reassessing the role of intra-arterial drug delivery for glioblastoma multiforme treatment. J Drug Deliv. 2015;2015:405735.CrossRefGoogle Scholar
  3. Ellis JA, Cooke J, Singh-Moon RP, Wang M, Bruce JN, Emala CW, Bigio IJ, Joshi S. Safety, feasibility, and optimization of intra-arterial mitoxantrone delivery to gliomas. J Neuro-Oncol. 2016;130(3):449–54.CrossRefGoogle Scholar
  4. Joshi S, Ellis JA, Emala CW. Revisiting intra-arterial drug delivery for treating brain diseases or is it “déjà-vu, all over again”? J Neuroanaesth Crit Care. 2014;1(2):108–15.CrossRefGoogle Scholar
  5. Joshi S, Singh-Moon R, Wang M, Chaudhuri DB, Ellis JA, Bruce JN, Bigio IJ, Straubinger RM. Cationic surface charge enhances early regional deposition of liposomes after intracarotid injection. J Neuro-Oncol. 2014;120(3):489–97.CrossRefGoogle Scholar
  6. Joshi S, Ellis JA, Ornstein E, Bruce JN. Intraarterial drug delivery for glioblastoma multiforme: will the phoenix rise again? J Neuro-Oncol. 2015;124(3):333–43.CrossRefGoogle Scholar
  7. Joshi S, Singh-Moon RP, Ellis JA, Chaudhuri DB, Wang M, Reif R, Bruce JN, Bigio IJ, Straubinger RM. Cerebral hypoperfusion-assisted intra-arterial deposition of liposomes in normal and glioma-bearing rats. Neurosurgery. 2015;76(1):92–100.CrossRefGoogle Scholar
  8. Joshi S, Cooke JR, Chan DK, Ellis JA, Hossain SS, Singh-Moon RP, Wang M, Bigio IJ, Bruce JN, Straubinger RM. Liposome size and charge optimization for intraarterial delivery to gliomas. Drug Deliv Transl Res. 2016;6(3):225–33.CrossRefGoogle Scholar
  9. Joshi S, Cooke JRN, Ellis JA, Emala CW, Bruce JN. Targeting brain tumors by intra-arterial delivery of cell-penetrating peptides: a novel approach for primary and metastatic brain malignancy. J Neuro-Oncol. 2017;135(3):497–506.CrossRefGoogle Scholar
  10. Nguyen J, Cooke JRN, Ellis JA, Deci M, Emala CW, Bruce JN, Bigio IJ, Straubinger RM, Joshi S. Cationizable lipid micelles as vehicles for intraarterial glioma treatment. J Neuro-Oncol. 2016;128(1):21–8.CrossRefGoogle Scholar
  11. Nguyen J, Hossain SS, Cooke JRN, Ellis JA, Deci MB, Emala CW, Bruce JN, Bigio IJ, Straubinger RM, Joshi S. Flow arrest intra-arterial delivery of small TAT-decorated and neutral micelles to gliomas. J Neuro-Oncol. 2017;133(1):77–85.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Department of NeurosurgeryHofstra Northwell School of Medicine, Lenox Hill HospitalNew YorkUSA
  2. 2.Department of AnesthesiaColumbia University Medical CenterNew YorkUSA

Personalised recommendations